NASA Plan's Critics Seek Smaller Module

PASADENA, CALIF—NASA's current plans for a space station are being challenged by advocates of a smaller station, more useful to scientists, that could be built more quickly and with fewer shuttle flights. This opposition has crystallized in recent weeks around two embattled figures: Peter Banks, the former chairman of NASA's task force on scientific uses of the space station, and Oliver P. Harwood, a senior engineer at Rockwell International. Banks, director of Stanford University's Space

Written byTa Heppenheimer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This opposition has crystallized in recent weeks around two embattled figures: Peter Banks, the former chairman of NASA's task force on scientific uses of the space station, and Oliver P. Harwood, a senior engineer at Rockwell International. Banks, director of Stanford University's Space Telecommunications Laboratory, resigned this spring as head of the 30-member task force after NASA rejected his panel's recommendations for changes in the space station. Harwood, who has been formally reprimanded by top officials of the billion-dollar defense and space contractor for stating his views, testified May 20 before a Senate committee looking into industrial uses of the space station.

Based on NASA briefings that suggested the possibility of obtaining a heavy-lift launch vehicle, Banks proposed an interim space station similar in size and capability to the Skylab station of the 1970s. "A large, well-appointed space station that appears in 1995 or 1996 won't be nearly as important ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies